Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Autoimmunity Reviews|November 9, 2018
Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective studyAdrien Mirouse, Raphaèle Seror, Eric Vicaut, et al.
Orphanet Journal of Rare Diseases|January 29, 2022
Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partumEugénie Koumakis, Valérie Cormier-Daire, Azeddine Dellal, et al.
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
NEJM Evidence|October 22, 2024
Infliximab versus Cyclophosphamide for Severe Behçet's SyndromeDavid Saadoun, Georgina Maalouf, Matheus Vieira, et al.
European Journal of Haematology|July 21, 2021
White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective studyJoris Galland, Benjamin Thoreau, Maxime Delrue, et al.
Viruses|April 30, 2021
D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 PatientsBenjamin Thoreau, Joris Galland, Maxime Delrue, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Prognosis and long term outcome of stenotic large vessel involvement in giant cell arteritisGeorgina Maalouf, Bérangère Arnould, Olivier Espitia, et al.
Clinical and Experimental Medicine|August 11, 2022
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseasesVincent Jachiet, Laure Ricard, Pierre Hirsch, et al.
Annals of the Rheumatic Diseases|November 19, 2020
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trialRenaud Felten, Valérie Devauchelle-Pensec, Raphaèle Seror, et al.
RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
Pageof 3